| Haeyang Chung, MD | |
|
11 E Harwood Ter, Palisades Park, NJ 07650-1424 | |
| (201) 313-1500 | |
| (201) 941-4157 |
| Full Name | Haeyang Chung |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 42 Years |
| Location | 11 E Harwood Ter, Palisades Park, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285670059 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA5927500 (New Jersey) | Primary |
| 208000000X | Pediatrics | 25MA5927500 (New Jersey) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hudson Md Group | 6103240478 | 67 |
News Archive
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.
E. coli O157 is the most common of the harmful strains of the bacteria and this interdisciplinary research has investigated not just its characteristics, but also how people understand E. coli O157 and how their behaviour affects the threats that it poses. E. coli O157 must be swallowed to infect people it can be contracted from food, water or by contact with farm animals, particularly sheep and cattle, and their faeces.
"African nations are not receiving adequate international funding to fight HIV/AIDS, leaving them to face catastrophic consequences without enough medication, an independent, global medical and humanitarian organization said Thursday," the Associated Press reports.
A pair of Florida State University researchers have received a major grant from the National Institutes of Health (NIH) to study ways of preventing the body from developing scar tissue around biomedical devices such as coronary artery stents - a problem that affects thousands of patients each year.
› Verified 2 days ago
| Entity Name | Dr Chung Medical Clinic P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902069925 PECOS PAC ID: 5395873327 Enrollment ID: O20100512000185 |
News Archive
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.
E. coli O157 is the most common of the harmful strains of the bacteria and this interdisciplinary research has investigated not just its characteristics, but also how people understand E. coli O157 and how their behaviour affects the threats that it poses. E. coli O157 must be swallowed to infect people it can be contracted from food, water or by contact with farm animals, particularly sheep and cattle, and their faeces.
"African nations are not receiving adequate international funding to fight HIV/AIDS, leaving them to face catastrophic consequences without enough medication, an independent, global medical and humanitarian organization said Thursday," the Associated Press reports.
A pair of Florida State University researchers have received a major grant from the National Institutes of Health (NIH) to study ways of preventing the body from developing scar tissue around biomedical devices such as coronary artery stents - a problem that affects thousands of patients each year.
› Verified 2 days ago
| Entity Name | Hudson Md Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497301998 PECOS PAC ID: 6103240478 Enrollment ID: O20200720001687 |
News Archive
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.
E. coli O157 is the most common of the harmful strains of the bacteria and this interdisciplinary research has investigated not just its characteristics, but also how people understand E. coli O157 and how their behaviour affects the threats that it poses. E. coli O157 must be swallowed to infect people it can be contracted from food, water or by contact with farm animals, particularly sheep and cattle, and their faeces.
"African nations are not receiving adequate international funding to fight HIV/AIDS, leaving them to face catastrophic consequences without enough medication, an independent, global medical and humanitarian organization said Thursday," the Associated Press reports.
A pair of Florida State University researchers have received a major grant from the National Institutes of Health (NIH) to study ways of preventing the body from developing scar tissue around biomedical devices such as coronary artery stents - a problem that affects thousands of patients each year.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Haeyang Chung, MD 11 E Harwood Ter, Palisades Park, NJ 07650-1424 Ph: (201) 313-1500 | Haeyang Chung, MD 11 E Harwood Ter, Palisades Park, NJ 07650-1424 Ph: (201) 313-1500 |
News Archive
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.
E. coli O157 is the most common of the harmful strains of the bacteria and this interdisciplinary research has investigated not just its characteristics, but also how people understand E. coli O157 and how their behaviour affects the threats that it poses. E. coli O157 must be swallowed to infect people it can be contracted from food, water or by contact with farm animals, particularly sheep and cattle, and their faeces.
"African nations are not receiving adequate international funding to fight HIV/AIDS, leaving them to face catastrophic consequences without enough medication, an independent, global medical and humanitarian organization said Thursday," the Associated Press reports.
A pair of Florida State University researchers have received a major grant from the National Institutes of Health (NIH) to study ways of preventing the body from developing scar tissue around biomedical devices such as coronary artery stents - a problem that affects thousands of patients each year.
› Verified 2 days ago
Sung-won Lee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7 Broad Ave, Suite 203, Palisades Park, NJ 07650 Phone: 201-941-2486 Fax: 201-941-1577 | |
Dr. Kyungkon Kenneth Choi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 340 Broad Ave, Palisades Park, NJ 07650 Phone: 201-592-1112 Fax: 201-592-0773 |